Citadel Advisors’s Oak Street Health, Inc. OSH Stock Holding History

Citadel Advisors’s Portfolio OSH Stock Details OSH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-361,400	Closed	-$14M	–	15732
2023 Q1	$14M	Sell	361,400 -10,600	-3%	-$342K	﹤0.01%	2367
2022 Q4	$8M	Sell	372,000 -119,600	-24%	-$2.5M	﹤0.01%	3136
2022 Q3	$12.1M	Buy	491,600 +79,900	+19%	+$2.11M	﹤0.01%	2490
2022 Q2	$6.77M	Sell	411,700 -48,700	-11%	-$946K	﹤0.01%	3257
2022 Q1	$12.4M	Buy	460,400 +365,300	+384%	+$7.7M	﹤0.01%	2637
2021 Q4	$3.15M	Sell	95,100 -40,200	-30%	-$1.52M	﹤0.01%	5243
2021 Q3	$5.75M	Sell	135,300 -199,200	-60%	-$10.7M	﹤0.01%	4040
2021 Q2	$19.6M	Buy	334,500 +193,500	+137%	+$11.5M	﹤0.01%	2103
2021 Q1	$7.65M	Buy	141,000 +102,100	+262%	+$5.68M	﹤0.01%	3412
2020 Q4	$2.38M	Buy	+38,900	New	+$2.04M	﹤0.01%	4994

Other funds holding OSH

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Citadel Advisors's OSH Position: Q2 2023 in Review

Citadel Advisors sold out of Oak Street Health, Inc. (OSH) in Q2 2023, closing a stake of 1,587,371 shares — an estimated $61.4M sold.

Citadel Advisors first reported a position in OSH in Q3 2020 and held it in 10 quarters. The position peaked at $61.4M in Q1 2023. 3 funds tracked by Wall St. Rank hold OSH as of Q2 2023.

Citadel Advisors reported no remaining Oak Street Health, Inc. position as of Q2 2023 after selling out during the quarter.
Citadel Advisors sold 1,587,371 Oak Street Health, Inc. shares in Q2 2023, an estimated $61.4M.
Citadel Advisors first reported a position in Oak Street Health, Inc. in Q3 2020 and held it in 10 quarters.
Citadel Advisors's Oak Street Health, Inc. position peaked at $61.4M in Q1 2023.
3 funds tracked by Wall St. Rank held Oak Street Health, Inc. as of Q2 2023.

Based on Citadel Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.